Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Leal da Costa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Portuguese Journal of Public Health|October 29, 2024
Medicines Evaluation: The "Simplified" ComplexityFernando Leal da Costa
Frontiers in Oncology|February 21, 2022
Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of HematologistsCatarina Geraldes, Manuel Neves, Sérgio Chacim, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 14, 2011
[A case of native valve infective endocarditis in an immunocompromised patient]Maria Salomé Carvalho, Marisa Trabulo, Regina Ribeiras, et al.
Acta Medica Portuguesa|June 28, 2005
[High-dose chemotherapy and stem-cell in patients with breast cancer]Raúl Lobato de Faria, Nuno Miranda, Fernando Leal da Costa, et al.
Frontiers in Medicine|December 17, 2020
Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence DecisionRogério Sá Gaspar, Beatriz Silva-Lima, Fernando Magro, et al.
Acta Medica Portuguesa|February 4, 2009
[Use of granulocyte growth factors: recommendations of the Portuguese Society of Hematology]João Forjaz de Lacerda, Fernando Leal da Costa, Ana Marques Pereira, et al.
Acta Medica Portuguesa|April 24, 2012
[High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series]Margarida Brito, Pedro Sanchez, Sónia Velho, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Acta Medica Portuguesa|August 19, 2009
[Biosimilars in oncology]Sérgio Barroso, Jorge Coutinho, Margarida Damasceno, et al.
The Oncologist|March 29, 2011
Multiple myeloma treatment strategies with novel agents in 2011: a European perspectiveHeinz Ludwig, Meral Beksac, Joan Bladé, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Portuguese Journal of Public Health|October 29, 2024
Medicines Evaluation: The "Simplified" ComplexityFernando Leal da Costa
Frontiers in Oncology|February 21, 2022
Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of HematologistsCatarina Geraldes, Manuel Neves, Sérgio Chacim, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 14, 2011
[A case of native valve infective endocarditis in an immunocompromised patient]Maria Salomé Carvalho, Marisa Trabulo, Regina Ribeiras, et al.
Acta Medica Portuguesa|June 28, 2005
[High-dose chemotherapy and stem-cell in patients with breast cancer]Raúl Lobato de Faria, Nuno Miranda, Fernando Leal da Costa, et al.
Frontiers in Medicine|December 17, 2020
Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence DecisionRogério Sá Gaspar, Beatriz Silva-Lima, Fernando Magro, et al.
Acta Medica Portuguesa|February 4, 2009
[Use of granulocyte growth factors: recommendations of the Portuguese Society of Hematology]João Forjaz de Lacerda, Fernando Leal da Costa, Ana Marques Pereira, et al.
Acta Medica Portuguesa|April 24, 2012
[High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series]Margarida Brito, Pedro Sanchez, Sónia Velho, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Acta Medica Portuguesa|August 19, 2009
[Biosimilars in oncology]Sérgio Barroso, Jorge Coutinho, Margarida Damasceno, et al.
The Oncologist|March 29, 2011
Multiple myeloma treatment strategies with novel agents in 2011: a European perspectiveHeinz Ludwig, Meral Beksac, Joan Bladé, et al.
Pageof 2